These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 32848008

  • 1. A Ceftazidime-Avibactam-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Strain Harboring blaKPC-14 Isolated in New York City.
    Niu S, Chavda KD, Wei J, Zou C, Marshall SH, Dhawan P, Wang D, Bonomo RA, Kreiswirth BN, Chen L.
    mSphere; 2020 Aug 26; 5(4):. PubMed ID: 32848008
    [Abstract] [Full Text] [Related]

  • 2. Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam.
    Galani I, Antoniadou A, Karaiskos I, Kontopoulou K, Giamarellou H, Souli M.
    Clin Microbiol Infect; 2019 Jun 26; 25(6):763.e5-763.e8. PubMed ID: 30928562
    [Abstract] [Full Text] [Related]

  • 3. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.
    Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, Pandey R, Doi Y, Kreiswirth BN, Nguyen MH, Clancy CJ.
    Antimicrob Agents Chemother; 2017 Mar 26; 61(3):. PubMed ID: 28031201
    [Abstract] [Full Text] [Related]

  • 4. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
    Zhang P, Shi Q, Hu H, Hong B, Wu X, Du X, Akova M, Yu Y.
    Clin Microbiol Infect; 2020 Jan 26; 26(1):124.e1-124.e4. PubMed ID: 31494252
    [Abstract] [Full Text] [Related]

  • 5. Reversion of KPC-114 to KPC-2 in ceftazidime-avibactam- resistant/meropenem-susceptible Klebsiella pneumoniae ST11 is related to low mutation rates.
    Pariona JGM, Vásquez-Ponce F, Becerra J, Martins-Gonçalves T, Pariona EMM, Madueño FT, Esposito F, V de Lima A, Mello Sampaio JL, Galhardo RS, Lincopan N.
    Microbiol Spectr; 2024 Oct 03; 12(10):e0117324. PubMed ID: 39190636
    [Abstract] [Full Text] [Related]

  • 6. Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization.
    Gaibani P, Re MC, Campoli C, Viale PL, Ambretti S.
    Clin Microbiol Infect; 2020 Apr 03; 26(4):516.e1-516.e4. PubMed ID: 31740422
    [Abstract] [Full Text] [Related]

  • 7. Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae.
    Venditti C, Butera O, Meledandri M, Balice MP, Cocciolillo GC, Fontana C, D'Arezzo S, De Giuli C, Antonini M, Capone A, Messina F, Nisii C, Di Caro A.
    Clin Microbiol Infect; 2021 Jul 03; 27(7):1040.e1-1040.e6. PubMed ID: 33775814
    [Abstract] [Full Text] [Related]

  • 8. Molecular Mechanisms Driving the In Vivo Development of KPC-71-Mediated Resistance to Ceftazidime-Avibactam during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.
    Li X, Ke H, Wu W, Tu Y, Zhou H, Yu Y.
    mSphere; 2021 Dec 22; 6(6):e0085921. PubMed ID: 34935448
    [Abstract] [Full Text] [Related]

  • 9. Effects of KPC Variant and Porin Genotype on the In Vitro Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae.
    Wilson WR, Kline EG, Jones CE, Morder KT, Mettus RT, Doi Y, Nguyen MH, Clancy CJ, Shields RK.
    Antimicrob Agents Chemother; 2019 Mar 22; 63(3):. PubMed ID: 30617090
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae.
    Zhang W, Guo Y, Li J, Zhang Y, Yang Y, Dong D, Zhu D, He P, Hu F.
    Antimicrob Resist Infect Control; 2018 Mar 22; 7():142. PubMed ID: 30479755
    [Abstract] [Full Text] [Related]

  • 11. Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent Klebsiella pneumoniae.
    Shi Q, Shen S, Tang C, Ding L, Guo Y, Yang Y, Wu S, Han R, Yin D, Hu F.
    Emerg Microbes Infect; 2024 Dec 22; 13(1):2361007. PubMed ID: 38801099
    [Abstract] [Full Text] [Related]

  • 12. Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo.
    Göttig S, Frank D, Mungo E, Nolte A, Hogardt M, Besier S, Wichelhaus TA.
    J Antimicrob Chemother; 2019 Nov 01; 74(11):3211-3216. PubMed ID: 31365094
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acquisition of a Stable and Transferable blaNDM-5-Positive Plasmid With Low Fitness Cost Leading to Ceftazidime/Avibactam Resistance in KPC-2-Producing Klebsiella pneumoniae During Treatment.
    Huang J, Zhang S, Zhao Z, Chen M, Cao Y, Li B.
    Front Cell Infect Microbiol; 2021 Nov 01; 11():658070. PubMed ID: 34354959
    [Abstract] [Full Text] [Related]

  • 16. Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime-avibactam due to a deletion in the blaKPC3 gene.
    Antinori E, Unali I, Bertoncelli A, Mazzariol A.
    Clin Microbiol Infect; 2020 Jul 01; 26(7):946.e1-946.e3. PubMed ID: 32061796
    [Abstract] [Full Text] [Related]

  • 17. Ceftazidime-Avibactam Resistance Associated with Increased blaKPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae.
    Coppi M, Di Pilato V, Monaco F, Giani T, Conaldi PG, Rossolini GM.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31964792
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In Vitro Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 Carbapenemases.
    Shields RK, Nguyen MH, Press EG, Chen L, Kreiswirth BN, Clancy CJ.
    Antimicrob Agents Chemother; 2017 May 24; 61(5):. PubMed ID: 28242667
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility evaluation of novel beta-lactam/beta-lactamase inhibitor combinations against carbapenem-resistant Klebsiella pneumoniae from bloodstream infections in hospitalized patients in Brazil.
    Wilhelm CM, Antochevis LC, Magagnin CM, Arns B, Vieceli T, Pereira DC, Lutz L, de Souza ÂC, Dos Santos JN, Guerra RR, Medeiros GS, Santoro L, Falci DR, Rigatto MH, Barth AL, Martins AF, Zavascki AP.
    J Glob Antimicrob Resist; 2024 Sep 24; 38():247-251. PubMed ID: 38936472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.